Related Experiment Video
Updated: Aug 6, 2025

Knee Arthrocentesis in Adults
Published on: February 25, 2022
SPILF update on bacterial arthritis in adults and children
Insights
This update provides guidance on antibiotic management for bacterial arthritis, emphasizing optimized dosing and administration for bone and joint infections. Recommendations cover dosage adjustments for specific conditions and treatment durations for various bacterial pathogens.
Area of Science:
- Infectious Diseases
- Rheumatology
- Pharmacology
Background:
- The French Society of Rhumatology (SFR) released updated guidelines for bacterial arthritis in 2020.
- This document supplements the SFR update, focusing on specific antibiotic strategies for bone and joint infections.
Framework:
- Recommendations emphasize antibiotics with optimal bone and joint penetration.
- Dosage optimization based on pharmacokinetic/pharmacodynamic (PK/PD) parameters is crucial.
Implementation:
- High-dose intravenous betalactams are recommended, utilizing continuous or intermittent infusion.
- Dosage adjustments for obesity and renal insufficiency are provided.
- Transition to oral antibiotics is advised once blood cultures are negative and clinical symptoms improve.
Implications:
- Specific treatment durations are outlined: 6 weeks for Staphylococcus aureus, 4 weeks for other bacteria, and 7 days for Neisseria.
- Consultation with an infectious disease (ID) physician is recommended for Enterobacter infections with high-dose susceptibility.
- Optimized antibiotic therapy can improve outcomes for bacterial arthritis.
Abstract:
In 2020 the French Society of Rhumatology (SFR) published an update of the 1990 recommendations for management of bacterial arthritis in adults. While we (French ID Society, SPILF) totally endorse this update, we wished to provide further information about specific antibiotic treatments. The present update focuses on antibiotics with good distribution in bone and joint. It is important to monitor their dosage, which should be maximized according to PK/PD parameters. Dosages proposed in this update are high, with the optimized mode of administration for intravenous betalactams (continuous or intermittent infusion). We give tools for the best dosage adaptation to conditions such as obesity or renal insufficiency. In case of enterobacter infection, with an antibiogram result "susceptible for high dosage", we recommend the requesting of specialized advice from an ID physician. More often than not, it is possible to prescribe antibiotics via the oral route as soon as blood cultures are sterile and clinical have symptoms shown improvement. Duration of antibiotic treatment is 6 weeks for Staphylococcus aureus, and 4 weeks for the other bacteria (except for Neisseria: 7 days).
Related Concept Videos
Bacterial Phylum Spirochaetes
Tonsillitis II: Management
Rheumatic Heart Disease III: Medical Management
Tonsillitis I: Introduction
Etiology
Three primary contributing factors have been identified.
Acute Pharyngitis
Acute pharyngitis is the inflammation of the back of the throat (pharynx), commonly resulting in a sore throat. It is a frequently encountered condition that prompts individuals to seek medical advice.
Classification
Acute pharyngitis can be categorized based on its underlying cause:
Genome-wide Association Studies-GWAS
GWAS does not require the identification of the target gene involved in...

